Investors / United States / OMX Ventures
OMX Ventures
Venture capital · Lincolnshire, IL, United States · North America
OMX Ventures is a venture capital firm that invests in early-stage biotech companies. It specializes in Seed and Series A funding and works closely with founders on team building, IP, and milestones to attract follow-on capital.
Invests inHealthcare & Biotech
In its own wordsbiotechtherapeuticssynthetic biologybio-toolsdiagnosticsartificial intelligence
Your fit with OMX Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsOMX Ventures lists 27 checked portfolio companies on its own site and is named in 3 funding rounds. Its most frequent entry is Series B, 67% of the companies with a known first round. Its largest themes are Healthcare & Biotech (96%) and Fintech (4%). 80% of its companies are based in United States. It invests most often alongside Paladin Capital Group, Axial and ARTIS.
Counts come from funding rounds that name OMX Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not OMX Ventures' whole history. Rounds on record name 3 companies; its own site lists 27. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 67% |
| Growth | 33% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 64th | 27 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 71th | 7% of companies confirmed by a round |
| Sector focus | 97th | 96% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Paladin Capital Group | 6 |
| Axial | 5 |
| ARTIS | 4 |
| Foresite Capital | 4 |
| +ND Capital | 3 |
| ARCH Venture Partners | 3 |
| RA Capital | 3 |
| SoftBank Vision Fund | 3 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2696%
- No longer answers00%
- Points to another company14%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 96% | 15% |
| Fintech | 4% | 12% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Paladin Capital Group
Compare OMX Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with OMX Ventures| Date | Company | Stage |
|---|---|---|
| 9 Nov 2026 | Series C+ | |
| 15 Apr 2026 | Series B | |
| 4 Sept 2025 | Series B |
Round details for OMX Ventures
Amounts, full round histories and every co-investor in OMX Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
27 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| Aperiam Bio identifies hyperfolding variants of target proteins with improved expression, solubility, and specific activity | Healthcare & Biotech | Portfolio page | ||
| Cellsonics develops and provides a tissue dissociation method using acoustic waves for single cell sample preparation. | Healthcare & Biotech | Portfolio page | ||
| Compass Pathways develops new clinical standards for mental health care using psychedelic treatment. | Healthcare & Biotech | Portfolio page | ||
| Constructive Bio designs and manufactures new-to-nature proteins for next-generation therapies. | Healthcare & Biotech | Portfolio page | ||
| Delix Therapeutics is developing novel therapeutics to address brain health challenges | Healthcare & Biotech | Nov 2026Series C+ | Page + round | |
| Epana Bio treats autoimmune disease by targeting its cellular origin and using genomics and AI to build medicines | Healthcare & Biotech | Portfolio page | ||
| Finch Therapeutics has a portfolio of innovative microbiome assets with potential applicability to a wide range of product strategies and therapeutic areas. | Healthcare & Biotech | Portfolio page | ||
| Freya Biosciences is a clinical-stage immunology company developing therapies to address inflammation and immune dysregulation in conditions affecting women. | Healthcare & Biotech | Portfolio page | ||
| General Inception partners with technical co-founders to solve problems of science-based company creation and helps them translate their deep tech vision to customers. | FintechHealthcare & Biotech | Portfolio page | ||
| Ginkgo Bioworks provides autonomous labs for biotechnology, allowing scientists to order experimental work from robots and focus on insight, creativity, and judgment rather than manual lab work. | Healthcare & Biotech | Portfolio page | ||
| Glyphic Biotechnologies is developing a high-throughput proteome sequencing technology | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| The company develops a platform for single-cell functional analysis to accelerate discovery and apply novel biological insights in research and drug discovery. | Healthcare & Biotech | Apr 2026Series B | Page + round | |
| Matterworks is developing artificial intelligence to predict biological outcomes in drug development | Healthcare & Biotech | Portfolio page | ||
| MRM Health develops microbiome-based therapeutics for chronic diseases | Healthcare & Biotech | Sept 2025Series B | Funding round | |
| ReAx Biotechnologies is a company that delivers therapies for challenging protein targets using its discovery platform. | Healthcare & Biotech | Portfolio page | ||
| Replay develops HSV vectors for gene therapy applications | Healthcare & Biotech | Portfolio page | ||
| Stipple Bio develops life-changing medicines for people with cancer using a precision-driven approach to oncology. | Healthcare & Biotech | Portfolio page | ||
| Syndex Bio develops and applies a novel platform technology called mcPCR for amplifying DNA methylation | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- omx.vc
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 4 Sept 2025
- Companies checked
- 27
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get OMX Ventures' profile as data
Pull OMX Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/omx.vc
# also
GET /v1/firms/omx.vc/portfolio
GET /v1/firms/omx.vc/coinvestors
GET /v1/firms/omx.vc/news